Atossa Genetics (NASDQ: ATOS) is a clinical-stage drug company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions.
Visit our YouTube channel to learn more about Atossa Genetics.
Atossa Genetics Announces 1 for 12 Reverse Stock Split
Atossa Genetics Requests Shareholders to Vote
Atossa Genetics Enrolls First Cohort of Eight Subjects in Endoxifen Study of Male Subjects
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!